VRVincent Rusanganwa

Vincent Rusanganwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vincent Rusanganwa has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enhancing clinical laboratory quality in Rwanda: addressing healthcare expectations and future fitness – insights from observations and perspectives of physicians and laboratory professionals

    by Innocent Nzabahimana, Fredinah Namatovu, Annette Uwineza, Vincent Rusanganwa

    Clinical laboratories are vital in healthcare, influencing medical decisions. As the field moves toward precision medicine and digital tools, laboratories


  • Open Access

    Disability, geographic and socioeconomic inequalities in access to insecticide-treated nets, and malaria prophylaxis among women in Uganda: A repeated cross-sectional study

    by Fredinah Namatovu, Vincent Rusanganwa

    Introduction: Although Uganda has made substantial progress in malaria prevention and control, it remains unclear whether these interventions have equitably reached all subpopulations. This study aimed to assess disability, geographic, and socioeconomic disparities in access to insecticide‑treated nets (ITN) and Fansidar prophylaxis among women in Uganda. Methods: This repeated cross-sectional study analyzed Uganda Demographic and Health Survey data from women aged 15–49 years. Data from 2006 and 2016 were used in this study as they mark the first and most recent years with available disability data, respectively. Three outcome variables were included: 1) lack of ITN ownership, defined as “yes” if the household had no ITNs and “no” if it had at least one; 2) lack of ITN use, coded “yes” if a woman did not sleep under an ITN the night before the survey and “no” if otherwise; and (3) lack of Fansidar prophylaxis uptake, considered “yes” if the participant did not take Fansidar during her last pregnancy and “no” if she did. The absolute risk differences (ARD) and the slope index of inequality (SII) were calculated for each survey period. An interaction term between the independent variables and the survey period was included to assess changes in access to malaria prevention measures, and all models were adjusted for age. Results: Between 2006 and 2016, the prevalence of lack of ITN ownership declined from 64.1% to 39.5%, lack of ITN use from 77.9% to 23.6%, and lack of Fansidar prophylaxis uptake from 77.9% to 35.1%. Inequalities in the lack of ITN ownership decreased significantly by education, wealth and place of residence, but not by disability. Similarly, for lack of ITN use, geographic and socio-economic inequalities declined during the two time points, while disability-related inequalities persisted. For lack of Fansidar prophylaxis uptake, inequalities decreased across all stratifiers; however, the reduction was statistically significant only for education and wealth. Conclusions: Our findings suggest improvements in lack of ITN ownership and lack of ITN use as well as in lack of uptake of Fansidar prophylaxis. While geographic and socioeconomic inequalities decreased, disability-related inequalities persisted suggesting uneven progress. Policymakers should address the widening disparities between women with disabilities and those without and continue prioritising all underserved groups.

  • Open Access

    Evidence of dengue virus exposure and associated risk factors in Rwanda

    by Vincent Rusanganwa, Brenda Bainda, Yong-Dae Gwon, Maud Mutsaers, Aron Sasu, Eric Seruyange, Sanctus Musafiri, Olivia Wesula Lwande, Magnus Evander


  • Open Access

    Global prevalence of naturally occurring Wolbachia in field-collected Aedes mosquitoes: a systematic review and meta-analysis

    by Tewelde Tesfaye Gebremariam, Polly Leung, Vincent Rusanganwa

    Background: Dengue is one of the leading causes of morbidity worldwide. Wolbachia- mediated dengue biocontrol has emerged as a novel strategy in recent decades and depends on a lack of Wolbachia in the natural populations of Aedes mosquitoes. Through a systematic review of the published literature, this study sought to estimate the natural occurrence of Wolbachia among field-collected Aedes mosquitoes worldwide. Methods: We conducted hand and systematic searches from PubMed, the Cochrane Library, and Google Scholar for all relevant published articles on Wolbachia infection in Aedes mosquitoes published before September 12, 2024. The prevalence estimates were analysed using a random effects meta-analysis, and a random effects meta-regression was performed to determine sources of heterogeneity in prevalence estimates. Results: Twenty-three studies with 16,997 field-collected Aedes mosquitoes from different countries worldwide were included. The meta-analysis revealed a global pooled prevalence of natural Wolbachia infection in Aedes mosquitoes of 57.7% (95% CI: 41.0–72.8%), which was six times higher in Ae. albopictus than Ae. aegypti (p Ae. aegypti to 87.1% (95% CI: 78.0–92.8%) in Ae. albopictus . Continentally, Asia had the highest percentage of Wolbachia infection in Ae. aegypti (7.1%), followed by Europe (5.0%), North America (1.9%), and Africa (0.7%). Similarly, Asia had the highest prevalence of Wolbachia in Ae. albopictus (95.5%), followed by Europe (94.8%), North America (91.6%), South America (85.2%), and Africa (71.6%). Overall, dengue incidence was negatively related to Wolbachia prevalence (B = −0.0006, p = 0.0281). Species wise, infection rates in Ae. aegypti were significantly higher among females than males (OR = 1.72; 95% CI = 1.01, 2.92, p = 0.046), while there was no difference between males and females in Ae. albopictus ( p = 0.098). Furthermore, Wolbachia infection rates in Ae. albopictus were inversely correlated with dengue incidence (β = −0.0013, p Ae. aegypti (p = 0.0984). In contrast, higher temperature was negatively associated with Wolbachia prevalence in Ae. aegypti but not in Ae. albopictus . In contrast, higher temperature was negatively associated with Wolbachia prevalence in Ae. aegypti (β = --2.5736, p Ae. albopictus (p = 0.7050). Conclusion: Aedes mosquitoes had a high and variable prevalence of naturally occurring Wolbachia , and this was negatively correlated with dengue incidence across countries. While the natural infection of Ae. albopictus is more common, detection in Ae. aegypti may reflect contamination and require high-quality multicentre studies to verify the above findings.


  • Open Access

    Quality and resilience of clinical laboratories in Rwanda: a need for sustainable strategies

    by Vincent Rusanganwa, Innocent Nzabahimana, Magnus Evander

    Quality healthcare is a global priority, reliant on robust health systems for evidence-based medicine. Clinical laboratories are the backbone of quality healthcare facilitating diagnostics, treatment, patient monitoring, and disease surveillance. Their effectiveness depends on sustainable delivery of accurate test results. Although the Strengthening Laboratory Management Towards Accreditation (SLMTA) programme has enhanced laboratory quality in low-income countries, the long-term sustainability of this improvement remains uncertain. To explore the sustainability of quality performance in clinical laboratories in Rwanda following the conclusion of SLMTA. A quasi-experimental design was adopted, involving 47 laboratories divided into three groups with distinct interventions. While one group received continuous mentorship and annual assessments (group two), interventions for the other groups (groups one and three) ceased following the conclusion of SLMTA. SLMTA experts collected data for 10 years through assessments using WHO's StepwiseLaboratory Quality Improvement Process Towards Accreditation (SLIPTA) checklist. Descriptive and t-test analyses were conducted for statistical evaluation. Improvements in quality were noted between baseline and exit assessments across all laboratory groups (mean baseline: 35.3%, exit: 65.8%, p < 0.001). However, groups one and three experienced performance declines following SLMTA phase-out (mean group one: 64.6% in reference to 85.8%, p = 0.01; mean group three: 57.3% in reference to 64.7%, p < 0.001). In contrast, group two continued to enhance performance even years later (mean: 86.6%compared to 70.6%, p = 0.03). A coordinated implementation of quality improvement plan that enables regular laboratory assessments to pinpoint and address the quality gaps is essential for sustaining quality services in clinical laboratories.


  • Open Access

    Arbovirus surveillance in febrile patients attending selected health facilities in Rwanda

    by Vincent Rusanganwa, Olivia Wesula Lwande, Brenda Bainda, Patrick I. Chiyo, Eric Seruyange, Göran Bucht, Magnus Evander

    Arthropod-borne (arbo) viruses cause emerging diseases that affect the livelihoods of people around the world. They are linked to disease outbreaks resulting in high morbidity, mortality, and economic loss. In sub-Saharan Africa, numerous arbovirus outbreaks have been documented, but the circulation and magnitude of illness caused by these viruses during inter-epidemic periods remains unknown in many regions. In Rwanda, there is limited knowledge on the presence and distribution of arboviruses. This study aimed at determining the occurrence and distribution of selected arboviruses, i.e., chikungunya virus (CHIKV), o’nyong-nyong virus (ONNV), dengue virus (DENV), West Nile virus (WNV), Zika virus (ZIKV), Rift Valley fever virus (RVFV) and Crimean-Congo haemorrhagic fever virus (CCHFV), among febrile patients visiting health centres in Rwanda. A total of 2294 dry blood spots (DBS) were collected on filter papers during August 2019 – December 2020. Reverse-transcription polymerase chain reaction (RT-PCR) was performed on samples in pools of ten, using both quantitative (DENV, ZIKV, RVFV) and conventional PCR (CHIKV, ONNV, WNV, CCHFV) with virus specific primers, followed by sequencing. Demographic data and clinical manifestations of illness were analysed. ONNV infection was detected in 12 of 230 pools (5.2%) and ZIKV in three pools (1.3%). The other arboviruses were not detected. All ONNV cases were found in the Rwaniro health centre, while ZIKV infection was found among patients visiting the Kirinda and Zaza health centres. There was temporal variability in ONNV infections with most cases being recorded during the long dry season, while ZIKV infection occurred during both dry and wet seasons. Patients with ONNV were older and more were females. In conclusion, ONNV and ZIKV infection were detected in acute patients and can explain some of the feverish diseases in Rwanda.


  • Open Access

    Physicians’ satisfaction with clinical referral laboratories in Rwanda

    by Vincent Rusanganwa, Jean Bosco Gahutu, Anna-Karin Hurtig, Magnus Evander

    The quality of laboratory services is crucial for quality of patient care. Clinical services and physicians’ decisions depend largely on laboratory test results for appropriate patients’ management...